5.4 C
7 December 2022
Economic and financial affairs Health and consumer protection News

EU adopts measures in support of generic pharmaceuticals producers

The EU is taking measures to foster the competitiveness of EU producers of generic medicines and biosimilar products. The Council today adopted a regulation which introduces an exception to the protection granted to an original medicine by a supplementary protection certificate (SPC) for export purposes and/or for stockpiling.

Thanks to the exception, EU-based manufacturers of generics and biosimilars will be entitled to manufacture a generic or biosimilar version of an SPC-protected medicine during the term of the SPC either for the purpose of exporting to a non-EU market where protection has expired or never existed or (during the six months before the SPC expires) for the purpose of creating a stock that will be put on the EU market after the SPC has expired.

The new regulation will enable generics manufacturers based within the EU to compete with non-EU manufacturers on equal terms. It will create high-value jobs and boost the availability of generic medicines in the EU.

Niculae BĂDĂLĂU, Romanian Minister of economy

More details here.

Related posts

Presentation of the external relations priorities of the Romanian Presidency of the EU Council in the European Parliament’s Committee on Foreign Affairs/AFET

Iulian Anghel

Deputy Prime Minister Vasile-Daniel Suciu: “Romania’s agenda for the Presidency of the European Union Council has put in the limelight the citizens and their needs”

Iulian Anghel

Informal Summit of Heads of State or Government of the European Union, Sibiu, May 9 – the press conference

Alexandru Stefan